Unexpected immunotherapy success in rare pancreatic cancer

A new case report was published in Oncotarget’s Volume 15 on October 11, 2024, entitled “A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy”

Understanding climate change effects on end stage kidney disease patients

Climate change is driving more extreme heat and more air pollution from wildfires, each of which put human health at risk.

October 24, 2024

PCP Visits Before Emergency Surgery Tied to Lower Mortality in Older Adults

Visiting a primary care provider (PCP) in the year prior to emergency general surgery was associated with lower postoperative mortality among Medicare patients, according to

July 20, 2023

Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

Ivonescimab — a novel first-in-class PD-1/VEGF bispecific antibody — led to clinically meaningful improvement in progression-free survival (PFS) compared with pembrolizumab (Keytruda) as first-line therapy

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.